Teresa Baczkowska
Overview
Explore the profile of Teresa Baczkowska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Czarnecka K, Czarnecka P, Tronina O, Baczkowska T, Durlik M
J Clin Med
. 2024 Mar;
13(6).
PMID: 38541944
Metabolic syndrome (MS) constitutes an important source of cardiovascular- and cancer-related morbidity and mortality in the general population. Limited information is available on whether these findings can be directly extrapolated...
2.
Czarnecka K, Czarnecka P, Tronina O, Baczkowska T, Durlik M
Transplant Proc
. 2024 Feb;
56(4):822-831.
PMID: 38403537
Background: Metabolic complications are a recognized health concern in liver transplant recipients that result in inferior patient-reported outcomes. Patients with MASH are known to be disproportionately affected by metabolic diseases...
3.
Kiryluk K, Sanchez-Rodriguez E, Zhou X, Zanoni F, Liu L, Mladkova N, et al.
Nat Genet
. 2023 Jun;
55(7):1091-1105.
PMID: 37337107
IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular deposition of IgA. Here we performed a genome-wide association study of 10,146 kidney-biopsy-diagnosed IgAN cases and 28,751...
4.
Czarnecka P, Czarnecka K, Tronina O, Baczkowska T, Wyczalkowska-Tomasik A, Durlik M, et al.
J Clin Med
. 2023 May;
12(10).
PMID: 37240622
Background: The chronic kidney disease (CKD) population, including kidney transplant recipients (KTRs) and subjects on renal replacement therapy, is particularly vulnerable to unfavorable outcomes from chronic hepatitis C (CHC). Currently,...
5.
Czarnecka P, Czarnecka K, Tronina O, Baczkowska T, Zarychta-Wisniewska W, Durlik M
J Clin Med
. 2023 Apr;
12(7).
PMID: 37048794
Chronic hepatitis C (CHC) is prevalent in the hemodialysis-dependent population. Currently, all patients with CHC should be considered for treatment; however, many hemodialysis-dependent patients are still left untreated. Following HCV...
6.
Czarnecka P, Czarnecka K, Baczkowska T, Lagiewska B, Durlik M
PLoS One
. 2023 Jan;
18(1):e0278894.
PMID: 36662740
Introduction: Calcineurin inhibitors constitute a cornerstone of immunosuppressive therapy in kidney transplant recipients. There are two main formulations of tacrolimus (Tac) which exhibit a prolonged-release mode of action: Advagraf® (MR-4)...
7.
Noninvasive Diagnostic Methods for the Assessment of Hepatic Fibrosis in Liver Transplant Recipients
Mikolajczyk-Korniak N, Baczkowska T, Tronina O, Durlik M
Transplant Proc
. 2022 Jun;
54(4):1042-1048.
PMID: 35660278
Background: Hepatic fibrosis in liver transplant recipients is the main predictive factor for graft function. Diagnostic methods for hepatic fibrosis staging should be available, reproducible, and noninvasive, if possible. We...
8.
Czarnecka P, Czarnecka K, Tronina O, Baczkowska T, Durlik M
Ren Fail
. 2022 Mar;
44(1):434-449.
PMID: 35260039
Kidney transplantation is the treatment of choice in end-stage renal disease. The main issue which does not allow to utilize it fully is the number of organs available for transplant....
9.
Bodnar-Broniarczyk M, Durlik M, Baczkowska T, Czerwinska K, Marszalek R, Pawinski T
Pharmaceutics
. 2021 Oct;
13(10).
PMID: 34683869
Tacrolimus (TAC) has a narrow therapeutic index and highly variable pharmacokinetic characteristics. Close monitoring of the TAC concentrations is required in order to avoid the risk of acute rejection or...
10.
Czarnecka K, Czarnecka P, Tronina O, Baczkowska T, Durlik M
Immun Inflamm Dis
. 2021 Oct;
10(1):3-21.
PMID: 34598315
The obesity pandemic has resulted in an increasing demand for liver transplantation and has significantly altered the profile of liver transplant candidates in addition to affecting posttransplantation outcomes. In this...